Currently out of the existing stock ratings of Boris Peaker, 22 are a HOLD (38.6%), 35 are a BUY (61.4%).

Boris Peaker

Work Performance Price Targets & Ratings Chart

Analyst Boris Peaker, currently employed at TD COWEN, carries an average stock price target met ratio of 64.3% that have a potential upside of 37.9% achieved within 140 days.

Boris Peaker’s has documented 104 price targets and ratings displayed on 20 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on HRTX, Heron Therapeuti at 14-Nov-2023.

Wall Street Analyst Boris Peaker

Analyst best performing recommendations are on CTIC (CTI BIOPHARMA CORP).
The best stock recommendation documented was for CTIC (CTI BIOPHARMA CORP) at 4/17/2023. The price target of $8 was fulfilled within 23 days with a profit of $3.6 (81.82%) receiving and performance score of 35.57.

Average potential price target upside

of $17.9 (157.68%) on HRTX (HERON THERAPEUTI).
of $17.03 (18.2%) on MRK (MERCK MPANY).
of $11.14 (11.61%) on SGEN (SEAGEN).

CLDX Celldex Therapeutics EBS Emergent Biosolutions HRTX Heron Therapeuti SGEN Seagen IRWD Ironwood Pharmaceuticals JNCE Jounce Therapeutics AADI Aadi Bioscience CTMX CytomX Therapeutics NKTR Nektar Therapeutics MRK Merck mpany CTIC CTi Biopharma Corp PCRX Pacira Pharmaceuticals ADCT ADC Therapeutics SA PNT POINT Biopharma Global MGNX MacroGenics CLSD Clearside Biomedical INCY yte MDGL Madrigal Pharmaceuticals MRSN Mersana Therapeutics STML Stemline Therapeutics

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Mara Goldstein (MIZUHO)